Nicoya Revenue and Competitors

Claim your profile

Kitchener, ON CAN



Growjo Ranking



Estimated Revenue & Valuation

  • Nicoya's estimated annual revenue is currently $18.9M per year.(i)
  • Nicoya's estimated revenue per employee is $191,010
  • Nicoya's total funding is $28.2M.

Employee Data

  • Nicoya has 99 Employees.(i)
  • Nicoya grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Nicoya Lifesciences is a nanotechnology company developing sensor products that will change the world of biotechnology, lifesciences, and healthcare. Our technology is based on the unique optical properties of nanomaterials, also called nanophotonics. Using revolutionary nanosensing technology, we can detect a wide range of biomolecules at extremely small concentrations in a compact, low cost, rapid, and easy to use format. Our first product is OpenSPR, which is a powerful and affordable instrument for label-free interaction analysis. Interactions between proteins, antibodies, DNA, RNA, peptides, polymers, and more can be studied with nanoscale resolution. This is critical for research and development applications in many fields from pharmaceuticals to diagnostics. OpenSPR is compact, portable, easy to use, and best of all, priced so everyone can afford it.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Nicoya News

2022-04-17 - How To Eat More Chan Seeds, a Dietary Staple in the Longevity Hotspot of Nicoya, Costa Rica

Amidst the tropical greens of the Nicoya Peninsula of Costa Rica grows the chan plant, which produces this lesser-known seed.

2022-04-17 - Pura Vida: Nina Parker's guide to Costa Rica's Nicoya Peninsula

Pura Vida: Nina Parker's guide to Costa Rica's Nicoya Peninsula. After spending a fortnight travelling around this famed Blue Zone,...

2022-04-06 - Vertical Harvest raises funds for expansion – Produce Blue Book

The round, led by food innovation-focused venture capital fund Nicoya AB (publ) of Stockholm, Sweden, and Raiven Capital of Toronto, Canada,...

2021-04-14 - Nicoya promised additional funding from federal government to develop COVID-19 test

Kitchener-Waterloo-based healthtech startup Nicoya has announced it is set to receive more financial support and advisory services from the Government of Canada to continue the research and development of its rapid, saliva-based COVID-19 antigen test, Atlas. Arjun Sudarsan, Nicoya’s CTO, claims ...

2021-04-06 - Nicoya Lifesciences receives additional funding for next-phase development of its rapid, saliva-based COVID-19 diagnostic test

KITCHENER, Ontario, April 6, 2021 /PRNewswire/ -- Nicoya Lifesciences, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, is pleased to announce that it is receiving additional advisory services and funding to continue research and develo ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Nicoya Executives

Arjun SudarsanCTO
Ryan DenommeFounder and CEO
Colin CalvertChief Financial Officer
Patrick SterlinaChief of Engineering
Brian WardVP Operations